Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 84, Issue 1, 2013, Pages 219-227

  Carvalho, Flávia Chiva ^a   Campos, Michel Leandro ^a   Peccinini, Rosângela Gonçalves ^a   Gremião, Maria Palmira Daflon ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antiretroviral; Liquid crystal precursor; Mucoadhesion; Nasal administration; Phase behavior; Stimuli sensitive drug delivery systems

Indexed keywords

ZIDOVUDINE;

ANIMAL TISSUE; ANISOTROPY; ANTIVIRAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LIQUID CRYSTAL; MATHEMATICAL MODEL; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; NOSE MUCUS; PHYSICAL CHEMISTRY; PLASMA CONCENTRATION-TIME CURVE; SHEAR RATE; SHEAR STRESS; SWINE; TEMPERATURE; TENSILE STRENGTH; TIME TO MAXIMUM PLASMA CONCENTRATION; VISCOSITY;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTI-RETROVIRAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; LIQUID CRYSTALS; MALE; NASAL MUCOSA; RATS; RATS, WISTAR; SWINE;

EID: 84876937725     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.11.021     Document Type: Article

References (35)

1. L. Geocze, S. Mucci, M.A. D Marco, L.A. Nogueira-Martins, and V.A. Citero Qualidade de vida e adesão ao tratamento anti-retroviral de pacientes portadores de HIV Rev. Saúde Pública 44 2010 743 749 http://dx.doi.org/10.1590/S0034-89102010000400019
2. D.D. Richman, D.M. Margolis, M. Delaney, W.C. Greene, D. Hazuda, and R.J. Pomerantz The challenge of finding a cure for HIV infection Science 323 2009 1304 1307 10.1126/science.1165706
3. E. Ojewole, I. Mackraj, P. Naidooa, and T. Govender Exploring the use of novel drug delivery systems for antiretroviral drugs Eur. J. Pharm. Biopharm. 70 3 2008 697 710 10.1016/j.ejpb.2008.06.020
4. N.K. Saksena, and D.N. Haddad Viral reservoirs an impediment to HAART: new strategies to eliminate HIV-1 Curr. Drug Targets Infect. Disord. 3 2003 179 206 10.2174/1568005033481187
5. F.C. Carvalho, R.M.M. Mainardes, and M.P.D. Gremião Exploring the nanotechnology-based drug delivery systems for AIDS treatment F.H. Kasenga, Understanding HIV/AIDS Management and Care-Pandemic Approaches in the 21st Century 2011 InTech Rijeka 367 384
6. M.I. Ugwoke, R.U. Agu, N. Verbeke, and R. Kinget Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives Adv. Drug Deliv. Rev. 57 2005 1640 1665 10.1016/j.addr.2005.07.009
7. R.M. Mainardes, M.C.C. Urban, P.O. Cinto, M.V. Chaud, R.C. Evangelista, and M.P.D. Gremião Lipossomes and micro/nanoparticles as colloidal carriers for nasal drug delivery Curr. Drug Deliv. 3 2006 275 285
8. L. Illum Nasal drug delivery-possibilities, problems and solutions J. Control. Rel. 87 2003 187 198
9. F.C. Carvalho, M.L. Bruschi, R.C. Evangelista, and M.P.D. Gremião Mucoadhesive drug delivery systems Braz. J. Pharm. Sci. 46 2010 1 17
10. C. He, S.W. Kim, and D.S. Lee In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery J. Control. Rel. 127 2008 189 207 10.1016/j.jconrel.2008.01.005
11. G.P. Andrews, T.P. Laverty, and D.S. Jones Mucoadhesive polymeric platforms for controlled drug delivery Eur. J. Pharm. Biopharm. 71 2009 505 518 10.1016/j.ejpb.2008.09.028
12. M. Malmsten Surfactants and Polymers in Drug Delivery 2002 Marcel Dekker New York
13. S. Singh Phase transitions in liquid crystals Phys. Rep. 324 2000 107 269
14. M. Makai, E. Csányi, Z. Némenth, and J. Pálinkás Structure and drug release of lamellar liquid crystals containing glycerol Int. J. Pharm. 256 2003 95 107
15. J.C. Shah, Y. Sadhale, and D.M. Chilukuri Cubic phase gels as drug delivery systems Adv. Drug Deliv. Rev. 47 2001 229 250
16. F.C. Carvalho, V.H.V. Sarmento, L.A. Chiavacci, M.S. Barbi, and M.P.D. Gremião Development and in vitro evaluation of surfactant systems for controlled release of zidovudine J. Pharm. Sci. 99 2010 2367 2374
17. F.C. Carvalho, M.S. Barbi, V.H.V. Sarmento, L.A. Chiavacci, F.M. Netto, and M.P.D. Gremião Surfactant systems for nasal AZT delivery: structural, rheological and mucoadhesive properties J. Pharm. Pharmacol. 62 2010 430 439 10.1211/jpp/62.04,0004
18. B.J. Boyd, D.V. Whittaker, S.M. Khoo, and G. Davey Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems Int. J. Pharm. 309 2006 218 226
19. M.L. Bruschi, D.S. Jones, H. Panzeri, O. Freitas, M.P.D. Gremião, and E.H.G. Lara Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties J. Pharm. Sci. 96 2007 2074 2089
20. F.C. Carvalho, H.R. Silva, G.M. Luz, M.S. Barbi, D.S. Landgraf, L.A. Chiavacci, V.H.V. Sarmento, and M.P.D. Gremião Rheological, mechanical and adhesive properties of surfactant-containing systems designed as a potential platform for topical drug delivery J. Biomed. Nanotecnol. 8 2012 1 10
21. K. Osth, J. Grasjo, and E.A. Bjork A new method for drug transport studies on pig nasal mucosa using a horizontal using chamber J. Pharm. Sci. 91 2002 1259 1273
22. C. Callens, J. Ceulemans, A. Ludwig, P. Foreman, and J.P. Remon Rheological study on mucoadhesivity of some nasal powder formulations Eur. J. Pharm. Biopharm. 55 2003 323 328
23. N. Franse, E. Bjork, and K. Edsman Changes in the mucoadhesion of powder formulations after drug application investigated with a simplified method J. Pharm. Sci. 97 2008 3855 3864 10.1002/jps
24. The United States Pharmacopoeial Convention 35th, Pharmaceutical, Forum, vol. 35, 2009, pp. 1-28.
25. A.C. Williams Transdermal and Topical Drug Delivery 2003 Pharmaceutical Press London
26. J. Siepmann, and N.A. Peppas Higuchi equation: derivation, applications, use and misuse Int. J. Pharm. 418 2011 6 12 10.1016/j.ijpharm.2011.03.051
27. R.W. Korsmeyer, R. Gurny, E. Doelker, P. Buri, and N.A. Peppas Mechanisms of solute release from porous hydrophilic polymers Int. J. Pharm. 15 1983 25 35
28. V. Papadopoulou, K. Kosmidis, M. Vlachou, and P. Macheras On the use of the Weibull function for the discernment of drug release mechanisms Int. J. Pharm. 309 2006 2006 44 50 10.1016/j.ijpharm.2005.10.044
29. P. Costa, and J.M.S. Lobo Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 3 2001 123 133
30. C.S. Brazel, and N.A. Peppas Modeling of drug release from swellable polymers Eur. J. Pharm. Biopharm. 49 2000 47 58
31. U.V. Banakar Pharmaceutical Dissolution Testing 1992 Marcel Dekker New York
32. P. Arora, S. Sharma, and S. Garg Permeability issues in nasal drug delivery Drug Discov. Today 7 2002 967 975
33. J.A. Nicolazzo, B.L. Reed, and B.C. Finnin Buccal penetration enhancers - how do they really work? J. Control. Rel. 105 2005 1 15 10.1016/j.jconrel.2005. 01.024
34. GlaxoSmithKline, Retrovir® (zidovudine), Tablets, Capsules, and Syrup. Initial U.S. Approval: 1987, revised: September 2008.
35. P.M. Ved, and K. Kim Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain Int. J. Pharm. 411 2011 1 9 10.1016/j.ijpharm.2011.02.040